• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国大规模人群中血管性血友病(VWD)的分子与临床特征:二代测序及CNVplex技术的应用

Molecular and clinical profile of VWD in a large cohort of Chinese population: application of next generation sequencing and CNVplex technique.

作者信息

Liang Qian, Qin Huanhuan, Ding Qiulan, Xie Xiaoling, Wu Runhui, Wang Hongli, Hu Yiqun, Wang Xuefeng

机构信息

Xuefeng Wang, Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, No.197 Ruijin Second Road, Shanghai, 200025, China, Tel.: +86 21 54667770, Fax: +86 21 64333548, E-mail:

出版信息

Thromb Haemost. 2017 Jul 26;117(8):1534-1548. doi: 10.1160/TH16-10-0794. Epub 2017 May 24.

DOI:10.1160/TH16-10-0794
PMID:28536718
Abstract

Von Willebrand disease (VWD), the most common inherited bleeding disorder, is characterised by a variable bleeding tendency, heterogeneous laboratory phenotype and race specific distribution of mutations. The present study aimed to determine the correlation of genotype and phenotype in 200 Chinese individuals from 90 unrelated families with VWD. Next generation sequencing (NGS) of the whole coding VWF, copy number analysis of VWF by CNVplex technique as well as a comprehensive phenotypic assessment were carried out in all index patients (IPs). We identified putative mutations in all IPs except five mild type 1 (85/90, 94.4 %). In total, 98 different mutations were detected, 62 (63.3 %) of which were reported for the first time (23 missense mutations, 1 regulatory mutation, 12 splice site mutations and 26 null mutations). Mutations p.Ser1506Leu and p.Arg1374His/Cys/Ser were the most frequent mutations in 2A (33 % of cases) and 2M VWD (67 % of cases), respectively. In addition, mutation p.Arg816Trp was detected repeatedly in type 2N patients, while mutation p.Arg854Gln, extremely common in Caucasians, was not found in our cohort. Thirty-three patients had two or more putative mutations. Unlike most cases of type 1 and type 2 VWD, which were transmitted dominantly, we presented seven severe type 1, two type 2A and one type 2M with autosomal recessive inheritance. Here the phenotypic data of patients with novel mutations will certainly contribute to the better understanding of the molecular genetics of VWF-related phenotypes.

摘要

血管性血友病(VWD)是最常见的遗传性出血性疾病,其特征为出血倾向各异、实验室表型异质性以及突变的种族特异性分布。本研究旨在确定来自90个无关家族的200名中国VWD患者的基因型与表型之间的相关性。对所有索引患者(IP)进行了整个VWF编码区的二代测序(NGS)、采用CNVplex技术对VWF进行拷贝数分析以及全面的表型评估。除了5例轻度1型患者外,我们在所有IP中均鉴定出了推定突变(85/90,94.4%)。总共检测到98种不同的突变,其中62种(63.3%)为首次报道(23种错义突变、1种调控突变、12种剪接位点突变和26种无义突变)。p.Ser1506Leu和p.Arg1374His/Cys/Ser突变分别是2A型(占病例的33%)和2M型VWD(占病例的67%)中最常见的突变。此外,在2N型患者中反复检测到p.Arg816Trp突变,而在我们的队列中未发现白种人中极为常见的p.Arg854Gln突变。33例患者有两个或更多推定突变。与大多数1型和2型VWD以显性方式遗传不同,我们报告了7例严重1型、2例2A型和1例2M型呈常染色体隐性遗传。此处具有新突变患者的表型数据肯定有助于更好地理解VWF相关表型的分子遗传学。

相似文献

1
Molecular and clinical profile of VWD in a large cohort of Chinese population: application of next generation sequencing and CNVplex technique.中国大规模人群中血管性血友病(VWD)的分子与临床特征:二代测序及CNVplex技术的应用
Thromb Haemost. 2017 Jul 26;117(8):1534-1548. doi: 10.1160/TH16-10-0794. Epub 2017 May 24.
2
Genotype-phenotype correlation in a cohort of Portuguese patients comprising the entire spectrum of VWD types: impact of NGS.一个涵盖所有血管性血友病(VWD)类型的葡萄牙患者队列中的基因型-表型相关性:二代测序的影响
Thromb Haemost. 2016 Jul 4;116(1):17-31. doi: 10.1160/TH15-07-0604. Epub 2016 Mar 17.
3
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm.西班牙血管性血友病的分子与临床特征(PCM-EVW-ES):一种新诊断模式的提议
Thromb Haemost. 2016 Jan;115(1):40-50. doi: 10.1160/TH15-04-0282. Epub 2015 Aug 6.
4
The genetics of Canadian type 3 von Willebrand disease: further evidence for co-dominant inheritance of mutant alleles.加拿大 3 型血管性血友病的遗传学:突变等位基因共显性遗传的进一步证据。
J Thromb Haemost. 2013 Mar;11(3):512-20. doi: 10.1111/jth.12130.
5
Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients.与不同血管性血友病 (VWD) 类型相关的血管性血友病因子基因中的突变分布在 VWD 患者队列中。
Thromb Haemost. 2012 Oct;108(4):662-71. doi: 10.1160/TH12-02-0089. Epub 2012 Aug 7.
6
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.1型/2E型(2A亚型IIE)血管性血友病、1型维琴察型血管性血友病以及由血管性血友病因子基因的D3、D4、B1 - B3和C1 - C2结构域突变引起的轻型1型血管性血友病的实验室诊断。血管性血友病因子多聚体及血管性血友病因子前肽/抗原比值的作用。
Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8.
7
Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.多聚体分析在血管性血友病(VWD)诊断中的作用:来自西班牙 PCM-EVW-ES 项目的经验。
PLoS One. 2018 Jun 20;13(6):e0197876. doi: 10.1371/journal.pone.0197876. eCollection 2018.
8
Application of genetic testing for the diagnosis of von Willebrand disease.遗传性血管性血友病(von Willebrand 病)的基因检测应用。
J Thromb Haemost. 2024 Aug;22(8):2115-2128. doi: 10.1016/j.jtha.2024.05.006. Epub 2024 May 16.
9
Diagnosis of inherited von Willebrand disease: a clinical perspective.遗传性血管性血友病的诊断:临床视角
Semin Thromb Hemost. 2006 Sep;32(6):555-65. doi: 10.1055/s-2006-949661.
10
A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture.来自670个患有血管性血友病家庭的1167名法国患者的实验室表型/基因型相关性:一种新的流行病学情况。
Medicine (Baltimore). 2016 Mar;95(11):e3038. doi: 10.1097/MD.0000000000003038.

引用本文的文献

1
Detection of a novel large fragment deletion in the alpha-globin gene cluster using the CNVplex technology.使用CNVplex技术检测α-珠蛋白基因簇中的新型大片段缺失。
Front Genet. 2025 Mar 10;16:1518392. doi: 10.3389/fgene.2025.1518392. eCollection 2025.
2
Application of genetic testing for the diagnosis of von Willebrand disease.遗传性血管性血友病(von Willebrand 病)的基因检测应用。
J Thromb Haemost. 2024 Aug;22(8):2115-2128. doi: 10.1016/j.jtha.2024.05.006. Epub 2024 May 16.
3
Nanobody activator improves sensitivity of the von Willebrand factor activity assay to multimer size.
纳米抗体激活剂提高了 von Willebrand 因子活性检测对多聚体大小的灵敏度。
J Thromb Haemost. 2024 Jul;22(7):2052-2058. doi: 10.1016/j.jtha.2024.04.015. Epub 2024 May 3.
4
Identification of Two Novel Variants of the Gene in Chinese Families with Duchenne Muscular Dystrophy.在中国杜氏肌营养不良症家族中鉴定该基因的两个新变体。
Pharmgenomics Pers Med. 2023 Aug 17;16:759-766. doi: 10.2147/PGPM.S416294. eCollection 2023.
5
Phenotypic and genotypic (exon 28) characterization of patients diagnosed with von Willebrand disease type 1 in Eastern Saudi Arabia.在沙特阿拉伯东部,对被诊断为血管性血友病 1 型的患者进行表型和基因型(外显子 28)特征分析。
J Med Life. 2023 Mar;16(3):428-433. doi: 10.25122/jml-2022-0276.
6
Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease.血管性血友病因子和凝血因子 VIII 基因的下一代测序:在诊断为血管性血友病的克罗地亚成年患者中的一项横断面研究。
Croat Med J. 2022 Apr 30;63(2):166-175. doi: 10.3325/cmj.2022.63.166.
7
Structural basis of von Willebrand factor multimerization and tubular storage.血管性血友病因子多聚体形成和管状储存的结构基础。
Blood. 2022 Jun 2;139(22):3314-3324. doi: 10.1182/blood.2021014729.
8
New advances in the diagnosis of von Willebrand disease.血管性血友病的诊断新进展。
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):596-600. doi: 10.1182/hematology.2019000064.
9
Two cases of von Willebrand disease type 3 in consanguineous Chinese families.两例近亲结婚的中国人患血管性血友病 3 型。
Mol Genet Genomic Med. 2020 Feb;8(2):e1075. doi: 10.1002/mgg3.1075. Epub 2019 Dec 2.
10
Phenotype and genotype of FXIII deficiency in two unrelated probands: identification of a novel F13A1 large deletion mediated by complex rearrangement.两例无关先证者 FXIII 缺陷的表型和基因型:新型 F13A1 大片段缺失的鉴定,该缺失由复杂重排介导。
Orphanet J Rare Dis. 2019 Jul 24;14(1):182. doi: 10.1186/s13023-019-1144-z.